Successful unmanipulated stem cell transplantation from HLA-haploidentical 3-loci-mismatched parents in two children with severe aplastic anemia not responding to immunosuppressive therapy

American Journal of Hematology

Volumn 85, Issue 5, 2010, Pages 389-390

  Wang, Zhidong ^a   Yan, Hongmin ^a   Zhu, Ling ^a   Wang, Hengxiang ^a  

^a AIR FORCE GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN;

APLASTIC ANEMIA; ARTICLE; CASE REPORT; CHILD; FEMALE; GENE LOCUS; HAPLOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SEVERE APLASTIC ANEMIA; TREATMENT RESPONSE;

ANEMIA, APLASTIC; CHILD, PRESCHOOL; DIRECTED TISSUE DONATION; FEMALE; GRAFT SURVIVAL; HAPLOTYPES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOSUPPRESSIVE AGENTS; SALVAGE THERAPY; TRANSPLANTATION CONDITIONING; TREATMENT FAILURE;

EID: 77951574505     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21693     Document Type: Article

References (11)

1. Gurion R, Gafter-Gvili A, Paul M, et al. Hematopoietic growth factors in aplastic anemia patients treated with immunosuppressive therapy-systematic review and meta-analysis. Haematologica 2009;94:712-719.
2. Osugi Y, Yagasaki H, Sako M, et al. Antithymocyte globulin and cyclosporine for treatment of 44 children with hepatitis associated aplastic anemia. Haematologica 2007;92:1687-1690. (Pubitemid 350248249)
3. Aversa F, Tabilio A, Velardi A, et al. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. N Engl J Med 1998;339:1186-1193. (Pubitemid 28482127)
4. Jin JD, Wang HX, Xiao FJ, et al. A novel rich source of human mesenchymal stem cells from the debris of bone marrow samples. Biochem Biophys Res Commun 2008;376:191-195.
5. Dey BR, Spitzer TR. Current status of haploidentical stem cell transplantation. Br J Haematol 2006;135:423-437. (Pubitemid 44583409)
6. Tsutsumi Y, Tanaka J, Miura T, et al. Successful non-T-cell-depleted nonmyeloablative hematopoietic stem cell transplantation (NST) from an HLA-haploidentical 2-loci-mismatched sibling in a heavily transfused patient with severe aplastic anemia based on the fetomaternal microchimerism. Bone Marrow Transplant 2004;34:267-269. (Pubitemid 39136834)
7. Lacerda JF, Martins C, Carmo JA, et al. Haploidentical stem cell transplantation with purified CD341 cells after a chemotherapy-alone conditioning regimen in heavily transfused severe aplastic anemia. Biol Blood Marrow Transplant 2005;11:399-400. (Pubitemid 40542933)
8. George B, Mathews V, Viswabandya A, et al. Fludarabine based reduced intensity conditioning regimens in children undergoing allogeneic stem cell transplantation for severe aplastic anemia. Pediatr Transplant 2008;12:14-19.
9. Maury S, Bacigalupo A, Anderlini P, et al. Improved outcome of patients older than 30 years receiving HLA-identical sibling hematopoietic stem cell transplantation for severe acquired aplastic anemia using fludarabine-based conditioning: A comparison with conventional conditioning regimen. Haematologica 2009;94:1312-1315.
10. Ji SQ, Chen HR, Yan HM, et al. Anti-CD25 monoclonal antibody (basiliximab) for prevention of graft-versus-host disease after haploidentical bone marrow transplantation for hematological malignancies. Bone Marrow Transplant 2005;36:349-354.
11. Tisato V, Naresh K, Girdlestone J, et al. Mesenchymal stem cells of cord blood origin are effective at preventing but not treating graft-versus-host disease. Leukemia 2007;21:1992-1999. (Pubitemid 47299975)